Compartmentalized Replication of SARS-Cov-2 in Upper vs. Lower Respiratory Tract Assessed by Whole Genome Quasispecies Analysis.
COVID-19
SARS-COV-2
coronavirus
quasispecies
variability
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
26 Aug 2020
26 Aug 2020
Historique:
received:
17
07
2020
revised:
22
08
2020
accepted:
24
08
2020
entrez:
30
8
2020
pubmed:
30
8
2020
medline:
30
8
2020
Statut:
epublish
Résumé
We report whole-genome and intra-host variability of SARS-Cov-2 assessed by next generation sequencing (NGS) in upper (URT) and lower respiratory tract (LRT) from COVID-19 patients. The aim was to identify possible tissue-specific patterns and signatures of variant selection for each respiratory compartment. Six patients, admitted to the Intensive Care Unit, were included in the study. Thirteen URT and LRT were analyzed by NGS amplicon-based approach on Ion Torrent Platform. Bioinformatic analysis was performed using both realized in-house and supplied by ThermoFisher programs. Phylogenesis showed clade V clustering of the first patients diagnosed in Italy, and clade G for later strains. The presence of quasispecies was observed, with variants uniformly distributed along the genome and frequency of minority variants spanning from 1% to ~30%. For each patient, the patterns of variants in URT and LRT were profoundly different, indicating compartmentalized virus replication. No clear variant signature and no significant difference in nucleotide diversity between LRT and URT were observed. SARS-CoV-2 presents genetic heterogeneity and quasispecies compartmentalization in URT and LRT. Intra-patient diversity was low. The pattern of minority variants was highly heterogeneous and no specific district signature could be identified, nevertheless, analysis of samples, longitudinally collected in patients, supported quasispecies evolution.
Identifiants
pubmed: 32858978
pii: microorganisms8091302
doi: 10.3390/microorganisms8091302
pmc: PMC7563410
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : European Commission - Horizon 2020
ID : EU project 653316-EVAg
Organisme : European Commission - Horizon 2020
ID : EU project 101003544 - CoNVat
Organisme : European Commission - Horizon 2020
ID : EU project 101003551 - EXSCALATE4CoV
Organisme : 3rd Health Programme JA
ID : EU project 848096 - SHARP.
Références
Infect Genet Evol. 2020 Sep;83:104351
pubmed: 32387564
Nat Biotechnol. 2011 May 15;29(7):644-52
pubmed: 21572440
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Emerg Infect Dis. 2020 Aug;26(8):1842-1845
pubmed: 32459984
N Engl J Med. 2004 Mar 25;350(13):1366-7
pubmed: 15044654
J Hepatol. 2019 Apr;70(4):593-602
pubmed: 30439392
Cold Spring Harb Mol Case Stud. 2016 Nov;2(6):a001214
pubmed: 27900364
Bioinformatics. 2012 Dec 1;28(23):3150-2
pubmed: 23060610
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Emerg Microbes Infect. 2020 Dec;9(1):221-236
pubmed: 31987001
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Clin Microbiol Infect. 2020 Jul 24;:
pubmed: 32717416
Clin Infect Dis. 2020 Jul 28;71(15):713-720
pubmed: 32129843
Annu Rev Microbiol. 2019 Sep 8;73:529-557
pubmed: 31226023
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
Zool Res. 2020 May 18;41(3):247-257
pubmed: 32351056
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Nat Commun. 2019 Jul 1;10(1):2898
pubmed: 31263112
Clin Microbiol Infect. 2020 Jul;26(7):954-956
pubmed: 32229288
New Microbiol. 2011 Oct;34(4):391-7
pubmed: 22143812
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Lancet Microbe. 2020 May;1(1):e14-e23
pubmed: 32835326